Worldwide Cost Estimate For Alzheimer's And Dementia Is US$315.4 Billion.
The 10/66 Dementia diagnosis* shows that the true prevalence of dementia may be much higher than previously estimated, particularly in the least developed regions.
Pilot studies conducted by the 10/66 Group in 26 centers in Latin America, Africa, India, Russia and China demonstrated the feasibility and validity of a simple, one stage dementia diagnosis for use in population-based research, known as the "10/66 Dementia diagnosis."
"Dementia is overwhelmingly the most important contributor to needs for care and caregiver strain in all the locations we studied," Prince says.
"Caregivers often cut back on work to care. There is a lack of awareness, health services are unresponsive, and many families do not seek, let alone receive, help."
The 10/66 Group has developed a low-level, brief caregiver education and training intervention, know as "Helping Carers to Care," which is now being evaluated in randomized trials in Russia, India, China and four Latin American centers. Prince will present encouraging early findings at the ADI conference.
"Earlier studies may have underestimated the prevalence of dementia in regions with low awareness of this emerging public health problem," Prince says.
"Primary healthcare services and governments have failed to respond to families' complex needs for long-term support.
Attention needs to be directed towards the development of age-appropriate healthcare, a long-term care policy, and mechanisms for ensuring, as a right, the social protection of older persons."
Prince adds, "Later this year, ADI will launch the first World Alzheimer Report alerting governments, policymakers and donors of the urgent need to give priority to these actions."....